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background: Studies show that brain natriuretic peptide (BNP) circulates in our body in various forms due to further biochemical processing. This 
is the first clinical study to assess the diagnostic potential of altered forms of BNP in differentiating heart failure (HF) from non-cardiac causes of 
dyspnea.
Methods: This is an 18 month single center prospective cohort study of 400 patients presenting to the emergency room with dyspnea or chest 
pain. For dyspnea, blood was drawn on presentation, 12-24 hours later, and on discharge. For chest pain, blood was drawn on presentation, within 6 
hours, and on discharge. 6 altered BNP forms were studied: BNP 77-108 Natrecor, proBNP 1*-108, proBNP 3*-108, BNP 79*-108, BNP 77-108 in 
House, & NTproBNP 1-76 Hytest.
results: Altered BNP forms 3*-108, 77-108 Natrecor, & 1*-108, yielded the highest diagnostic sensitivity/specificity values of 90/75.8, 
93.3/77.4, 93.3/83.8 respectively. Areas under a Receiver Operator Characteristic curve were .919, .922, & .919 respectively as well (all within 
95% CI). 1*-108 increased diagnostic accuracy the most by a regression coefficient of 98 (P<0.005) when combined with other BNP forms in a 
multimarker approach. HF patients showed a 3:1 ratio of peptides to patients without HF or left ventricular dysfunction.
conclusion: Altered forms of BNP demonstrate significant diagnostic accuracy in identifying HF. A multimarker approach that includes the ratios of 
altered forms may improve diagnosis and validate improved prognosis.
